Clinical and economic characteristics associated with type 2 diabetes

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Revista Clinica Espanola

• Publication date

  2014-04-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1016/J.RCENG.2014.01.001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

  2015cited by this paper
• Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrospective analysis.

  2013cited by this paper
• [Costs of temporary disability in Spain related to diabetes mellitus and its complications].

  2013cited by this paper
• Incidence of diabetes and serum adipokines in Catalonian men. The ADIPOCAT study

  2013cited by this paper
• Consecuencias clínicas y económicas de la combinación de metformina con inhibidores de la dipeptidilpeptidasa en pacientes con diabetes tipo 2

  2013cited by this paper
• [Incidence and prevalence of diabetes in an adult population of Madrid (Spain): a study using computerized medical records in primary care].

  2013cited by this paper
• Costs of temporary disability in Spain related to diabetes mellitus and its complications

  2013cited by this paper
• Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2013cited by this paper
• Patient Preferences for the Treatment of Type 2 Diabetes: A Scoping Review

  2013cited by this paper
• Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes

  2012cited by this paper
• Fifteen years of continuous improvement of quality care of type 2 diabetes mellitus in primary care in Catalonia, Spain

  2012cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.

  2012cited by this paper
• The economic rationale for adherence in the treatment of type 2 diabetes mellitus.

  2012cited by this paper
• Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival.

  2012cited by this paper
• Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes.

  2012cited by this paper
• Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain

  2012cited by this paper
• Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association.

  2011cited by this paper
• National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

  2011cited by this paper
• The impact of diabetes mellitus on healthcare costs in Italy

  2011cited by this paper
• Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis.

  2011cited by this paper
• [Hypoglycemia in the elderly with diabetes mellitus].

  2010cited by this paper
• Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paper

  2010cited by this paper
• [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].

  2010cited by this paper
• Hipoglucemia en el anciano con diabetes mellitus

  2010cited by this paper
• [Prevalence of diabetes mellitus and cardiovascular risk factors in the adult population of the autonomous region of Madrid (Spain): the PREDIMERC study].

  2010cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs.

  2009cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Evolución de la prevalencia de la diabetes tipo 2 en población adulta española

  2007cited by this paper
• Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).

  2007cited by this paper
• Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary

  2007cited by this paper
• Coste de la diabetes mellitus en España

  2006cited by this paper
• Relationship of Glycemic Control to Total Diabetes-Related Costs for Managed Care Health Plan Members With Type 2 Diabetes

  2005cited by this paper
• Direct health care costs of diabetic patients in Spain.

  2004cited by this paper
• Estudio de los costes directos sanitarios de los pacientes con diabetes mellitus en España

  2004cited by this paper
• Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study

  2003cited by this paper
• American Diabetes Association position statement: evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications.

  2002cited by this paper
• El coste de la diabetes tipo 2 en España. El estudio CODE-2

  2002cited by this paper
• How should cost data in pragmatic randomised trials be analysed?

  2000cited by this paper
• Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

  1999cited by this paper
• How to Break Bad News

  1994cited by this paper
• The Internatinal classification of primary care in the European community : multi-language layer

  1993cited by this paper
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

  1993cited by this paper
• Development and Application of a Population-Oriented Measure of Ambulatory Care Case-Mix

  1991cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper

• Comparative analysis of burden of topmost disorders requiring rehabilitation services: a systematic review and meta-analysis

  2025cites this paper
• Investigating the change in gene expression profile of blood mononuclear cells post-laparoscopic sleeve gastrectomy in Chinese obese patients

  2023cites this paper
• Resource use and costs in patients with poorly controlled type 2 diabetes mellitus and obesity in routine clinical practice in Spain

  2020cites this paper
• Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus

  2019cites this paper
• Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature Review

  2019influential citation
• Pharmacological control of diabetes and hypertension comorbidity in the elderly: A study of "real world" data.

  2017cites this paper
• Trabajo de Titulación presentado en conformidad con los requisitos establecidos para optar por el título de Médico Cirujano

  2014cites this paper